These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6848907)
1. Has one diabetic complication been explained? Winegrad AI; Simmons DA; Martin DB N Engl J Med; 1983 Jan; 308(3):152-4. PubMed ID: 6848907 [No Abstract] [Full Text] [Related]
2. [New theories of the pathogenesis of diabetic neuropathies]. Lekishvili VP Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612 [No Abstract] [Full Text] [Related]
3. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
6. The sorbitol pathway and the complications of diabetes. Gabbay KH N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466 [No Abstract] [Full Text] [Related]
7. The sorbitol pathway. Enzyme localization and content in normal and diabetic nerve and cord. Gabbay KH; O'Sullivan JB Diabetes; 1968 May; 17(5):239-43. PubMed ID: 4384869 [No Abstract] [Full Text] [Related]
8. Diabetes mellitus--present problems and new research. VI. Nephropathy and neuropathy. Sharkey TP J Am Diet Assoc; 1971 May; 58(5):442-4. PubMed ID: 4324852 [No Abstract] [Full Text] [Related]
9. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine. Malone JI; Lowitt S; Corsico N; Orfalian Z Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404 [TBL] [Abstract][Full Text] [Related]
10. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications]. Greene DA; Sima AA; Lattimer SA Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181 [No Abstract] [Full Text] [Related]
11. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Jacobson M; Sharma YR; Cotlier E; Hollander JD Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448 [TBL] [Abstract][Full Text] [Related]
12. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]. Christensen JE; Larsen AB; Gregersen G Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975 [No Abstract] [Full Text] [Related]
16. The effects of sorbinil on the pathophysiology of diabetic complications. Proceedings of a symposium. Dorado, Puerto Rico, May 30-June 2, 1985. Metabolism; 1986 Apr; 35(4 Suppl 1):1-121. PubMed ID: 3083196 [No Abstract] [Full Text] [Related]
17. [Sorbitol and its role in nutrition]. Maĭstruk PN; Germaniuk IaL Vopr Pitan; 1983; (1):3-5. PubMed ID: 6340351 [No Abstract] [Full Text] [Related]
18. [The biochemical basis of the complications of diabetes]. Gabbay KH Journ Annu Diabetol Hotel Dieu; 1984; ():307-20. PubMed ID: 6443221 [No Abstract] [Full Text] [Related]